Related Experiment Videos
[Signal transduction abnormalities in systemic lupus erythematosus]
György Nagy1, Pál Géher, Agnes Koncz
1Semmelweis Egyetem, Altalános Orvostudományi Kar, 111. Belgyógyászati Klinika Reumatológiai es Fizioterápiás Tanszéki Csoport, I. Részleg, Budai Irgalmasrendi Kórház, Budapest.
Orvosi Hetilap
|September 15, 2005
Summary
Nitric oxide (NO) increases mitochondrial mass in T cells, mimicking lupus T cell abnormalities. This mitochondrial biogenesis may explain altered calcium signaling and offers new therapeutic targets for systemic lupus erythematosus (SLE).
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Context:
- T cell activation is regulated by T cell receptors and cytokines, involving calcium (Ca2+) signaling.
- Nitric oxide (NO) and reactive oxygen intermediates are emerging mediators of T cell activation.
- Mitochondria play crucial roles in cellular signaling, Ca2+ handling, and cell death pathways.
Purpose:
- To investigate the role of nitric oxide (NO) in T cell activation and mitochondrial dynamics.
- To explore the link between NO-induced mitochondrial changes and calcium signaling abnormalities in T cells.
- To determine if NO contributes to the pathogenesis of systemic lupus erythematosus (SLE).
Summary:
- Nitric oxide (NO) induces mitochondrial biogenesis in lymphocytes, increasing mitochondrial mass and altering Ca2+ handling.
- Lupus T cells exhibit increased mitochondrial mass and altered Ca2+ signaling, with elevated NO levels observed in SLE patients.
- Exposure of normal T cells to NO mimics the mitochondrial and Ca2+ abnormalities seen in lupus T cells.
Impact:
- Increased mitochondrial biogenesis due to NO may underlie altered Ca2+ handling in T cells.
- These findings identify NO-induced mitochondrial changes as potential therapeutic targets for SLE.
- Understanding these mechanisms could lead to novel pharmacological interventions for autoimmune diseases like SLE.